Latest market price
9.13
-0.60-6.17%
OverviewShort InterestFilings
BCAXQT9Bicara Therapeutics Inc. Common Stock·NASDAQ
9.13-6.17%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Sep 10, 20264Statement of changes in beneficial ownership
Sep 08, 2026144Notice of proposed sale of restricted securities
Sep 08, 2026144Notice of proposed sale of restricted securities
Aug 25, 20268-KCurrent report
Aug 14, 20264Statement of changes in beneficial ownership
Aug 14, 20263Initial statement of beneficial ownership
Aug 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Aug 11, 2026S-8Registration of employee benefit securities
Aug 10, 2026144Notice of proposed sale of restricted securities
Aug 10, 2026144Notice of proposed sale of restricted securities
Aug 10, 2026144Notice of proposed sale of restricted securities
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20263Initial statement of beneficial ownership
Jul 29, 20264Statement of changes in beneficial ownership
Jul 29, 20263Initial statement of beneficial ownership
Jul 28, 20268-KCurrent report
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 14, 20264Statement of changes in beneficial ownership
Jul 10, 2026144Notice of proposed sale of restricted securities
#1 / 25 of 262
Page
▼
/ 11